Abstract
Human cytomegalovirus (HCMV) represents one of the most medically important human viruses and causes a wide spectrum of human diseases, including birth defects and mental retardation in newborns, common opportunistic infections in aquired immunodeficiency syndrom (AIDS) patients (e.g., CMV-associated retinitis and pneumonia), and possibly cardiovascular diseases such as atherosclerosis. This chapter describes the utilization of RNase P ribozyme—specifically, M1GS ribozyme, as a gene-targeting agent for blocking HCMV gene expression and growth. The target for the RNase P ribozyme is the overlapping region of the mRNAs that code for HCMV major transcription factors IE1 and IE2, which are essential for viral gene expression and replication. The methods described in this chapter focus primarily on i) construction of the retroviral vector for expression of M1GS ribozymes in cultured cells, ii) generation of stable cell lines expressing ribozymes, iii) determination of the expression of M1GS RNAs in human cells, and iv) evaluation of the efficacy of ribozymes in inhibiting HCMV IE1/IE2 expression and viral growth. Using these methods, we successfully constructed M1GS RNAs against the IE1/IE2 mRNA sequence and recently showed that a reduction of up to 150- to 3000-fold in HCMV growth is found in cells that express the ribozymes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Altman, S. and Kirsebom, L. A. (1999) RNase P, in The RNA World (Gesteland, R. F., Cech T. R., and Atkins J. F., ed.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 351–380.
Forster, A. C. and Altman, S. (1990) External guide sequences for an RNA enzyme. Sciencea 249, 783–786.
Liu, F. and Altman, S. (1995) Inhibition of viral gene expression by the catalytic RNA subunit of RNase P from Escherichia coli. Genes Devel. 9, 471–480.
Yuan, Y., Hwang, E. S. and Altman, S. (1992) Targeted cleavage of mRNA by human RNase P. Proc. Natl. Acad. Sci. USA 89, 8006–8010.
Plehn-Dujowich, D. and Altman, S. (1998) Effective inhibition of influenza virus production in cultured cells by external guide sequences and ribonuclease P. Proc. Natl. Acad. Sci. USA 95, 7327–7332.
Kawa, D., Wang, J., Yuan, Y. and Liu, F. (1998) Inhibition of viral gene expression by human ribonuclease P. RNA 4, 1397–1406.
Frank, D. N. and Pace, N. R. (1998) Ribonuclease P: unity and diversity in a tRNA processing ribozyme. Annu. Rev. Biochem. 67, 153–180.
Cobaleda, C. and Sanchez-Garcia, I. (2001) RNase P: from biological function to biotechnological applications. Trends Biotechnol. 19, 406–411.
Trang, P., Lee, M., Nepomuceno, E., Kim, J., Zhu, H., and Liu, F. (2000) Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli. Proc. Natl. Acad. Sci. USA 97, 5812–5817.
Trang, P., Lee, J., Kilani, A. F., Kim, J., and Liu, F. (2001) Effective inhibition of herpes simplex virus 1 gene expression and growth by engineered RNase P ribozyme. Nucleic Acids Res. 29, 5071–5078.
Das, G., Henning, D., and Reddy, R. (1987) Structure, organization, and transcription of Drosophila U6 small nuclear RNA genes. J. Biol. Chem. 262, 1187–1193.
Bertrand, E., Castanotto, D., Zhou, C., Carbonnelle, C., Lee, N. S., Good, P., et al. (1997) The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization. RNA 3, 75–88.
Good, P. D., Krikos, A. J., Li, S. X., Bertrand, E., Lee, N. S., Giver, L., et al. (1997) Expression of small, therapeutic RNAs in human cell nuclei. Gene Ther. 4, 45–54.
Yu, M., Ojwang, J., Yamada, O., Hampel, A., Rapapport, J., Looney, D., and Wong-Staal, F. (1993) A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90, 6340–6344.
Cobaleda, C. and Sanchez-Garcia, I. (2000) In vivo inhibition by a site-specific catalytic RNA subunit of RNase P designed against the BCR-ABL oncogenic products: a novel approach for cancer treatment. Blood 95, 731–737.
Mocarski, E. S. and Courcelle, C. T. (2001) Cytomegaloviruses and their replication, in Fields Virology, 3rd ed., (Knipe, D. M. a. H., P.M., ed.), Lippincott-Williams & Wilkins, Philadelphia, PA, pp. 2629–2673.
Trang, P., Kilani, A., Lee, J., Hsu, A., Liou, K., Kim, J., et al. (2002) RNase P ribozymes for the studies and treatment of human cytomegalovirus infections. J. Clin. Virol. 25, 63–74.
Yuan, Y. and Liu, F. (1998) Targeted cleavage of RNA using external guide sequences and eukaryotic RNase P, in Therapeutic Applications of Ribozymes (Scanlon, J. K., ed.), Humana Press, Totowa, NJ, pp. 397–413.
Miller, A. D. and Rosman, G. J. (1989) Improved retroviral vectors for gene transfer and expression. Biotechniques 7, 989,990.
Kim, J. J., Kilani, A. F., Zhan, X., Altman, S., and Liu, F. (1997) The protein cofactor allows the sequence of an RNase P ribozyme to diversify by maintaining the catalytically active structure of the enzyme. RNA 3, 613–623.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Trang, P., Liu, F. (2004). RNase P Ribozyme As an Antiviral Agent Against Human Cytomegalovirus. In: Sioud, M. (eds) Ribozymes and siRNA Protocols. Methods in Molecular Biologyâ„¢, vol 252. Humana Press. https://doi.org/10.1385/1-59259-746-7:437
Download citation
DOI: https://doi.org/10.1385/1-59259-746-7:437
Publisher Name: Humana Press
Print ISBN: 978-1-58829-226-1
Online ISBN: 978-1-59259-746-8
eBook Packages: Springer Protocols